(Q41054029)

26 September 2017

title

Differential ability of cells to promote oxidation of low density lipoproteins in vitro (English)

1 reference

26 September 2017

Fernando RL

1

1 reference

26 September 2017

Varghese Z

series ordinal

2

1 reference

26 September 2017

Moorhead JF

series ordinal

3

1 reference

26 September 2017

publication date

1 January 1998

1 reference

26 September 2017

1 reference

26 September 2017

volume

269

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

159-173

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

In vivo inhibition of foam cell development by probucol in Watanabe rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Low density lipoprotein undergoes oxidative modification in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

The oxidative modification of low density lipoprotein by human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Oxidized low-density lipoprotein in experimental focal glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Stable cell lines of T-SV40 immortalized human glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Lipoprotein oxidation and lipoprotein-induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Effects of dietary fatty acids in an animal model of focal glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Oxidized low-density lipoprotein stimulates protein kinase C (PKC) and induces expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 macrophage-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Role of superoxide in endothelial-cell modification of low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Role of endothelial cells and their products in the modification of low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

Cellular mechanisms of lipid injury in the glomerulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900199-X

10.1016/S0009-8981(97)00199-X

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference